Spravato/Esketamine Clinic

The HCMH Mental Health & Wellness Center is proud to offer SPRAVATO® (esketamine) as a new service for treatment-resistant depression. SPRAVATO® is the first FDA-approved nasal spray medication specifically for adults with treatment-resistant depression. If you’ve tried two or more antidepressants* and are still struggling with depressive symptoms, SPRAVATO® may offer relief.

The referral process is a key step in your path to recovery. Healthcare providers can refer a patient by completing our Spravato Referral Form (below) and submitting the necessary documentation. When complete fax the completed form and documents to 515-332-7572 - for questions please call our clinic at 515-332-7672. 

Referral Form  How To Refer A Patient

 

Frequently Asked Questions

What is SPRAVATO®?

SPRAVATO® is a prescription nasal spray that’s used along with an antidepressant (taken by mouth) to treat:

  • Adults with treatment-resistant depression (TRD)
  • Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions

*SPRAVATO is not for use as a medicine to prevent or relieve pain (anesthetic).

 

Is SPRAVATO® covered by insurance?

Most insurance plans cover SPRAVATO® when prescribed by a physician. Contact your insurance provider to confirm coverage. 

 

How is SPRAVATO® nasal spray different than ketamine infusions?

SPRAVATO® (esketamine) CIII nasal spray is a derivative of ketamine. SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. Ketamine has not been approved by the FDA to treat depression. Both SPRAVATO® and ketamine are Schedule III controlled substances under the US Controlled Substances Act.

 

Why can't I drive on the day of my SPRAVATO® treatment session? 

SPRAVATO® may cause sleepiness (sedation or loss of consciousness), fainting, dizziness, spinning sensation, anxiety or feeling disconnected from yourself, your thoughts, feelings and things around you (dissociation). For these reasons, do not drive, operate machinery or do anything where you need to be completely alert until the day after a treatment session, following a restful sleep, even if you think you feel well enough to do so.

 

How will I take SPRAVATO®?

  • You will take SPRAVATO® nasal spray yourself, under the supervision of an HCMH healthcare provider in the HCMH Mental Health & Wellness Center. Your healthcare provider will show you how to use the SPRAVATO® nasal spray device.
  • Your healthcare provider will tell you how much SPRAVATO® you will take and when you will take it.
  • Follow your SPRAVATO® treatment schedule exactly as your healthcare provider tells you to.
  • During and after each use of the SPRAVATO® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting.
  • You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO®.
  • If you miss a SPRAVATO® treatment, your healthcare provider may change your dose and treatment schedule.
  • Some people taking SPRAVATO® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO® and not drink liquids at least 30 minutes before taking SPRAVATO®.
  • If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO®.

 

The most common side effects of SPRAVATO® include:

  • feeling disconnected from yourself, your thoughts, feelings and things around you
  • dizziness
  • nausea
  • feeling sleepy
  • spinning sensation
  • decreased feeling of sensitivity (numbness)
  • feeling anxious
  • lack of energy
  • increased blood pressure
  • vomiting
  • feeling drunk
  • headache
  • feeling very happy or excited